Product
VCL-CB01
1 clinical trial
6 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Chronic Myelogenous LeukemiaIndication
Acute Myeloid LeukemiaIndication
Hodgkin lymphomaIndication
Non-Hodgkin lymphomaIndication
Myelodysplastic SyndromeClinical trial
A Phase 2 Clinical Trial to Evaluate the Safety, Immunogenicity, and Clinical Benefit of a CMV Immunotherapeutic Vaccine in Donors and CMV-Seropositive Recipients Undergoing Allogeneic, Matched Hematopoietic Cell Transplant (HCT)Status: Completed, Estimated PCD: 2009-11-30